If there’s one positive outcome of the COVID-19 pandemic, it’s the speed at which diagnostic test makers learned to develop and begin churning out kits to test for a virus. Roche, for one, is already ...

New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets to be detected simultaneously in a single patient sample on the high throughput molecular diagnostic analysers ...

(RTTNews) - The U.S. Food and Drug Administration has granted 510(k) clearance for the cobas SARS-CoV-2 Qualitative PCR test for use on the fully automated cobas 6800 and cobas 8800 Systems, Swiss ...

Roche AG’s new test using its temperature-activated generation of signal technology is the next step in PCR evolution, Igor Kozlov, head of Reagent Research and Design at Roche Diagnostics Solutions, ...

Add Yahoo as a preferred source to see more of our stories on Google. This past winter, hospitals and clinics across Indiana filled up with patients suffering from different respiratory illnesses that ...

ZURICH, Jan 26 (Reuters) - Roche (ROG.S), opens new tab has launched a new PCR test to detect a fast-spreading sub-variant of the Omicron variant of Coronavirus, the Swiss drugmaker said on Thursday.

Roche is rolling out what it describes as a new type of infectious disease diagnostic in Europe, with a single test capable of screening for up to 12 of the most common respiratory viruses at once.

Roche announced the CE Mark for its cobas ® BV/CV (Bacterial Vaginosis/Candida Vaginitis) assay to accurately identify specific bacteria and yeast responsible for BV and CV in vaginal samples from ...

Multiplex PCR Assay for cobas 4800 system uses self-collected male urine and vaginal swab samples. FDA granted 510(k) clearance for Roche’s cobas® CT/NG Test for detecting Chlamydia trachomatis (CT) ...